$SLGL News

Sol-Gel Technologies Q1 EPS $(1.31) Beats $(1.84) Estimate, Sales $108.000K Miss $900.000K Estimate

US Equity Indexes Fall Amid Uncertainty Over US-Iran Truce Talks

Reported Earlier, Sol-Gel Technologies Prices 459,112 Shares At $72 Per Share In Oversubscribed Underwritten Offering Raising Approximately $33.1M

Reported Earlier, Sol-Gel Technologies Prices 459,112 Shares At $72 Per Share In Oversubscribed Underwritten Offering Raising Approximately $33.1M

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates

Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025

Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 940% return over the last year

HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Raises Price Target to $110

Sol-Gel Technologies: Downgrading To 'Hold' As Success Relies On Upcoming Q4 Catalyst

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth

HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $50 Price Target

Why Is Small Cap Sol-Gel Tech Stock Falling Today?

Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease

Sol-Gel Says Phase 1b Study Of Sgt-210 In Darier Disease Did Not Differentiate Versus Vehicle, Will Not Advance Program And Will Focus On Phase 3 Sgt-610 In Gorlin Syndrome

Sol-Gel Technologies Q3 EPS $(2.13) Misses $(2.09) Estimate, Sales $400.000K Beat $300.000K Estimate

Insiders At Sol-Gel Technologies See Good Returns After Buying Stock Worth US$867.1k

HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Raises Price Target to $50

Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 240% return over the last year

Sol-Gel Announces Health Canada Approval of EPSOLAY®